High Court Won't Review Glenmark's $16M Tarka Patent Loss
The U.S. Supreme Court won't hear Glenmark Pharmaceuticals Ltd.'s bid to overturn a $16 million jury verdict that found the generic-drug maker had infringed a patent licensed by Abbott Laboratories for...To view the full article, register now.
Already a subscriber? Click here to view full article